MORRIS PLAINS, N.J., June 8, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that nine presentations will be given at the 56th Annual Meeting of the Society of Nuclear Medicine (SNM), scheduled for June 13 - 17, 2009, in Toronto, Canada. The schedule and meeting places for the oral presentations and scientific poster sessions, together with the publication numbers are listed below:
